ACACB and Insulin resistance: Genetic and pharmacological studies to inhibit or activate genes involved in fatty acid synthesis (ACC2) or oxidation (CPT1, MCD, AMPK) have produced conflicting results supporting the benefits of skeletal muscle mitochondrial fatty acid oxidation in models of diet induced insulin resistance[5,25-31].